Activation and inhibition of lymphocytes by costimulation

Journal of Clinical Investigation

Volumn 109, Issue 3, 2002, Pages 295-299

  Frauwirth, Kenneth A ^a   Thompson, Craig B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3BETA; GUANOSINE TRIPHOSPHATASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPID; PROTEIN CDC42; PROTEIN KINASE B; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN PROTEIN LIGASE; VAV PROTEIN;

ANTIBODY TITER; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0036170440     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214941     Document Type: Review

References (57)

1. Role of the CD28 receptor in T-cell activation
2. T cell co-stimulatory molecules other than CD28
3. T cells: A proliferation of costimulatory molecules
4. Costimulation in antiviral immunity: Differential requirements for CD4(+) and CD8(+) T cell responses
5. CD28/B7 system of T cell costimulation
6. Networking Rho family GTPases in lymphocytes
7. Signaling through CD28/CTLA-4 family receptors: Puzzling participation of phosphatidylinosicol-3 kinase
8. A point mutation in CD28 distinguishes proliferative signals from survival signals
9. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo
10. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha
11. On guard: Activating NK cell receptors
12. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
13. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B
14. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and 1FN-gamma but not TH2 cytokines
15. Adapters in lymphocyte signaling
16. Lymphocyte signalling: A coordinating role for Vav?
17. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
18. Cbl-b regulates the CD28 dependence of T-cell activation
19. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
20. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response
21. CD3- and CD28-dependent induction of PDE7 required for T cell activation
22. Elevation of intracellular cyclic AMP induces an anergic-like state in Th1 clones
23. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion ofalloreactive human and mouse helper T lymphocytes
24. CD28/B7 regulation of Th1 and Th2 subsets in the development ofautoimmune diabetes
25. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production
26. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis
27. Functional responses and costimulator dependence of memory CD4+ T cells
28. The expanding B7 superfarmly: Increasing complexity in costimulatory signals regulating T cell function
29. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses
30. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
31. ICOS co-stimulatory receptor is essential for T-cell activation and function
32. ICOS is critical for CD40-mediated antibody class switching
33. ICOS is essential for effective T-helper-cell responses
34. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha
35. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS
36. Characterization of human inducible costimulator ligand expression and function
37. The emerging role of CTLA-4 as an immune attenuator
38. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement
39. CTLA-4 (CD 152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression
40. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4
41. Molecular basis of T cell inactivation by CTLA-4
42. The CD28 and CTLA4 receptors associate with the serine/threonine phosphatase PP2A
43. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70
44. Genetic analysis of protein tyrosine phosphatases
45. Regulation of protein kinase cascades by protein phosphatase 2A
46. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail
47. Cutting edge: Tyrosine-independent transmission of inhibitory signals by CTLA-4
48. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation
49. Structural analysis of CTLA-4 function in vivo
50. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
51. PD-L2 is a second ligand for PD-I and inhibits T cell activation
52. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
53. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunorecepcor
54. ITAMs versus ITIMs: Striking a balance during cell regulation
55. Immunoreceptor tyrosine-based inhibition motifs
56. B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production
57. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4